Correlation of Clinical Response to Nilotinib with BCR-ABL Mutation Status in Advanced Phase Chronic Myelogenous Leukemia (CML-AP) Patients with Imatinib-Resistance or Intolerance.
暂无分享，去创建一个
J. Radich | G. Martinelli | G. Saglio | P. Erben | S. Soverini | A. Hochhaus | Dong-Wook Kim | N. Gallagher | S. Branford | A. Haque | Y. Shou | T. Hughes